Li J, Kuang X H, Zhang Y, Hu D M, Liu K
Department of General Surgery, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang 621000, China.
Department of Hematology, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang 621000, China.
Public Health. 2022 Sep;210:58-64. doi: 10.1016/j.puhe.2022.06.010. Epub 2022 Jul 20.
Gastric cancer in adolescents and young adults (GCAYA) has been ignored by both patients and physicians. We examined the disease burden of GCAYA and its secular trends in incidence and mortality.
A comprehensive analysis of the global burden of GCAYA based on data provided by GLOBOCAN 2020.
Global, regional, sex, and country-specific data of the incidence and mortality of GCAYA were extracted from the GLOBOCAN, the Cancer in Five Continents Plus, and the World Health Organization mortality database, respectively. The associations between the Human Development Index (HDI) and GCAYA burden were also evaluated by Pearson correlation analysis.
The global incidence of GCAYA was 0.79 per 100,000, and the corresponding mortality was 0.45 per 100,000 in 2020. The mortality-to-incidence ratio (MIR) was lower in AYA (0.61) than in patients aged 40-64 years (0.65) and patients aged 65 years and older (0.75). The age-standardized incidence rates (ASIR) and age-standardized mortality rates (ASMR) were 0.84 and 0.53 per 100,000, respectively, in women, compared with 0.74 and 0.45 per 100,000, respectively, in men. The majority of new cases (17,934) and deaths (10,360) were estimated to occur in Asia. There has a significant negative correlation between the MIR of GCAYA and HDI level (R = 0.2707, P < 0.0001). There was a decreasing trend of incidence and mortality in most countries.
The MIR of GCAYA is lower than that among older patients and exhibit a positive association with socio-economic status. The incidence and mortality of GCAYA show a decreasing trend in most countries.
青少年和青年胃癌(GCAYA)一直被患者和医生所忽视。我们研究了GCAYA的疾病负担及其发病率和死亡率的长期趋势。
基于GLOBOCAN 2020提供的数据对GCAYA的全球负担进行综合分析。
分别从GLOBOCAN、《五大洲癌症加》和世界卫生组织死亡率数据库中提取GCAYA发病率和死亡率的全球、区域、性别和特定国家数据。还通过Pearson相关分析评估了人类发展指数(HDI)与GCAYA负担之间的关联。
2020年GCAYA的全球发病率为每10万人0.79例,相应死亡率为每10万人0.45例。青少年和青年的死亡率与发病率之比(MIR)(0.61)低于40 - 64岁患者(0.65)和65岁及以上患者(0.75)。女性的年龄标准化发病率(ASIR)和年龄标准化死亡率(ASMR)分别为每10万人0.84例和0.53例,而男性分别为每10万人0.74例和0.45例。估计大多数新发病例(17,934例)和死亡病例(10,360例)发生在亚洲。GCAYA的MIR与HDI水平之间存在显著负相关(R = 0.2707,P < 0.0001)。大多数国家的发病率和死亡率呈下降趋势。
GCAYA的MIR低于老年患者,且与社会经济地位呈正相关。大多数国家GCAYA的发病率和死亡率呈下降趋势。